Related Experiment Videos
Spinal cord compression in metastatic prostate cancer
H Tazi1, A Manunta, A Rodriguez
1Service d'Urologie, Centre Hospitalier Universitaire Pontchaillou, Rue Henri Le, Guilloux, 35033 Cedex, Rennes, France.
European Urology
|October 24, 2003
Summary
Spinal cord compression in metastatic prostate cancer has a poor prognosis. Early imaging and prophylactic radiotherapy for persistent back pain in hormone-resistant prostate cancer may prevent severe neurological deficits.
Area of Science:
- Oncology
- Neurology
- Radiotherapy
Background:
- Spinal cord compression (SCC) affects 1-12% of patients with metastatic prostate cancer.
- This study analyzes outcomes and prognostic factors for patients treated for SCC at a single institution.
Purpose of the Study:
- To assess the outcomes of patients treated for spinal cord compression due to metastatic prostate cancer.
- To identify prognostic factors influencing survival and functional recovery in these patients.
Main Methods:
- Retrospective analysis of 24 patients hospitalized with SCC from metastatic prostate cancer (1987-2001).
- Data collected included neurological status at presentation, diagnostic methods (myelogram, CT, MRI), prior treatments, and interventions (steroids, orchidectomy, radiotherapy, laminectomy).
Main Results:
- At presentation, patients ranged from ambulant with mild deficit to paraplegic.
- 15 out of 24 patients were ambulant post-treatment; those treated with laminectomy and radiotherapy showed better outcomes (8/9 ambulant) than radiotherapy alone (7/12 ambulant).
- Median survival was 4 months, with 7 patients alive at a mean follow-up of 10 months.
Conclusions:
- The prognosis for patients with spinal cord compression from metastatic prostate cancer is generally poor.
- Preventive strategies are crucial, especially for hormone-resistant prostate cancer.
- Patients with persistent back pain and suspected bony metastases should undergo prompt imaging and consider prophylactic radiotherapy.